Venture(US:VEMLY) Zheng Quan Shi Bao Wang·2025-06-09 01:44Core Viewpoint - The financing balance of the ChiNext market has increased, with a notable rise in certain stocks, while others have seen a significant decrease in their financing balances [1][2]. Financing Balance Overview - The latest financing balance for ChiNext stocks is 342.14 billion yuan, an increase of 680 million yuan from the previous period, marking a continuous increase over four trading days [1]. - The total margin balance for ChiNext stocks is 343.07 billion yuan, with a net increase of 672 million yuan compared to the previous trading day [1]. - There are 476 stocks with increased financing balances, with 25 stocks seeing an increase of over 10% [1]. Notable Stocks with Increased Financing Balances - The stock with the highest increase in financing balance is Gongda Keya, which saw a rise of 42.43% to 41.90 million yuan, despite a price drop of 8.76% [3]. - Other notable stocks with significant increases include Aoke Co. (38.94%) and Maipu Medical (35.72%) [3]. - On average, stocks with over 10% increase in financing balance experienced a decline of 0.67% in price, with 14 stocks rising, including Xice Testing (11.06%) and Linuo Pharmaceutical (8.85%) [1][3]. Stocks with Decreased Financing Balances - A total of 457 stocks saw a decrease in financing balances, with 54 stocks experiencing a decline of over 5% [4]. - The stock with the largest decrease is Aoya Co., with a financing balance of 49.67 million yuan, down 22.67% [4]. - Other significant declines were observed in Hengerd (14.20%) and Jundingda (13.41%) [4]. Capital Flow Analysis - Among the stocks with increased financing balances, 14 stocks saw net inflows of main funds, with the highest inflows in Tuosida (183 million yuan) and Huibo Yuntong (178 million yuan) [2]. - Conversely, 11 stocks experienced net outflows, with Aoke Co. leading at 189 million yuan [2].